1,303
Views
17
CrossRef citations to date
0
Altmetric
Laboratory Study

Losartan Alleviates Renal Fibrosis by Down-Regulating HIF-1α and Up-Regulating MMP-9/TIMP-1 in Rats with 5/6 Nephrectomy

, , , , , , & show all
Pages 1297-1304 | Received 14 May 2012, Accepted 14 Aug 2012, Published online: 24 Sep 2012

REFERENCES

  • Renal Data US, System USRDS. 2011 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2011.
  • Gilbertson DT, Liu J, Xue JL, . Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol. 2005;16(12):2753–2758.
  • Zhang L, Wang F, Wang L, . Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet. 2012;379(9818):815–822.
  • Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol. 2006;17:17–25.
  • Kimura K, Iwano M, Higgins DF, . Stable expression of HIF-1α in tubular epithelial cells promotes interstitial fibrosis. Am J Physiol Renal Physiol. 2008;295(4):F1023–F1029.
  • Basu RK, Hubchak S, Hayashida T, . Interdependence of HIF-1α and TGF-β/Smad3 signaling in normoxic and hypoxic renal epithelial cell collagen expression. Am J Physiol Renal Physiol. 2011;300(4):F898–F905.
  • Page EL, Chan DA, Giaccia AJ, . Hypoxia-inducible factor-1{alpha} stabilization in nonhypoxic conditions: role of oxidation and intracellular ascorbate depletion. Mol Biol Cell. 2008;19:86–94.
  • Rüster C, Wolf G. Angiotensin II as a morphogenic cytokine stimulating renal fibrogenesis. Am Soc Nephrol. 2011;22(7):1189–1199.
  • Tang L, Yi R, Yang B, . Valsartan inhibited HIF-1α pathway and attenuated renal interstitial fibrosis in streptozotocin-diabetic rats. Diabetes Res Clin Pract. 2012;97(1):125–131.
  • Raij L, Azar S, Keane W. Mesangial immune injury, hypertension, and progressive glomerular damage in Dahl rats. Kidney Int. 1984;26(2):137–143.
  • Masaomi N, Reiko I, Toshio M, . Hypoxia and hypoxia-inducible factor in renal disease. Nephron Exp Nephrol. 2008;110(1):e1–e7.
  • Li X, Kimura H, Hirota K, . Synergistic effect of hypoxia and TNF-alpha on Production of PAI-l in human proximal renal tubular cells. Kindey Int. 2005;68(2):569–583.
  • Kuroda T, Yoshida Y, Kamiie J, . Expression of MMP-9 in mesangial cells and its changes in anti-GBM glomerulonephritis inWKY rats. Clin Exp Nephrol. 2004;8(3):206–215.
  • Ding HL, Guo Y, Xu MT, . Effect of angiotensin II receptor blocker on glucoseinduced mRNA expressions of martrix metallopromteinase-9 and tissue inhibitor of metall oproteinase-1 in rat mesangial cells. Chin Med J. 2007;120(21):1886–1889.
  • Schelter F, Halbgewachs B, Baumler P, . Tissue inhibitor of metalloproteinases-1-induced scattered liver metastasis is mediated by hypoxia-inducible factor-1α. Clin Exp Metastasis. 2011;28(2):91–99.
  • Marumo T, Hishikawa K, Matsuzaki Y, . Angiotensin II type 1 receptor blockade prevents decrease in adult stem like cells in kidney after ureteral obstruction. Eur J Pharmacol. 2007;573:216–220.
  • Wang Z, Tang L, Zhu Q, et al. Hypoxia-inducible factor-1α contributes to the profibrotic action of angiotensin II in renal medullary interstitial cells. Kidney Int. 2011;79(3):300–310.
  • Kong X, Zhang DY, Wu HB, et al. Losartan and pioglitazone ameliorate nephropathy in experimental metabolic syndrome rats. Biol Pharm Bull. 2011;34(5):693–699.
  • Meier P, Maillard MP. Combining blockers of the renin-angiotensin system or increasing the dose of an angiotensin II receptor antagonist in proteinuric patients: a randomized triple-crossover study. Hypertension. 2011;29(6):1228–1235.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.